1. The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis Gengiah, Tanuja N.; Holford, Nicholas H. G.; Botha, Julia H.; Gray, Andrew L.; Naidoo, Kogieleum; Abdool Karim, Salim 2012 Articles VirologyEpidemiology
2. Initiating antiretrovirals during tuberculosis treatment: a drug safety review Gengiah, Tanuja N.; Gray, Andrew L.; Naidoo, Kogieleum; Abdool Karim, Quarraisha 2011 Articles VirologyEpidemiology
3. Integration of Antiretroviral Therapy with Tuberculosis Treatment Abdool Karim, Salim; Naidoo, Kogieleum; Grobler, Anneke C.; Padayatchi, Nesri; Baxter, Cheryl; Gray, Andrew L.; Gengiah, Tanuja N.; Gengiah, Santhanalakshmi; Naidoo, Anushka; Jithoo, Niraksha; Nair, Gonasagrie; El-Sadr, Wafaa Mahmoud; Friedland, Gerald; Abdool Karim, Quarraisha 2011 Articles VirologyEpidemiology
4. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis Abdool Karim, Quarraisha; Abdool Karim, Salim; Baxter, Cheryl; Friedland, Gerald; Gengiah, Tanuja N.; Gray, Andrew L.; Grobler, Anneke C.; Naidoo, Kogieleum; Padayatchi, Nesri; El-Sadr, Wafaa Mahmoud 2010 Articles VirologyEpidemiology
5. Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy Abdool Karim, Salim; Naidoo, Kogieleum; Grobler, Anneke C.; Padayatchi, Nesri; Baxter, Cheryl; Gray, Andrew L.; Gengiah, Tanuja N.; Nair, Gonasagrie; Bamber, Sheila; Singh, Aarthi; Khan, Munira; Pienaar, Jacqueline; El-Sadr, Wafaa Mahmoud; Friedland, Gerald; Abdool Karim, Quarraisha 2010 Articles Public healthVirologyEpidemiology